Glaukos officer proposes $99.6K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GLAUKOS Corp (GKOS) officer Tomas Navratil reports a proposed sale of 716 common shares, with an approximate sale date of July 1, 2026, and an aggregate market value of $99,566.96. The notice lists March 12, 2026, as the Rule 10b5-1 plan adoption or instruction date. The shares came from restricted stock vesting on March 24, 2025, as compensation. During the prior three months, Navratil reported sales of 2,093 shares for gross proceeds of $246,177.94 on April 10, 2026, and 1,537 shares for gross proceeds of $200,855.16 on June 16, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.